Other
Hemodynamic
1
Pipeline Programs↗
18
Active Trials↗
6
Companies Involved↗
Hemodynamic is an early-stage landscape with 1 program across 6 companies. The most active players are Novartis, Prism Pharmaceuticals, Tenax Therapeutics, Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
89
clinical trials
Completed53 · 60%
Recruiting13 · 15%
Unknown status11 · 12%
Terminated5 · 6%
Not yet recruiting3 · 3%
Withdrawn2 · 2%
Other2 · 2%
Clinical Trials
Trial Activity
89 trials
Individual Cerebral Hemodynamic Oxygenation Relationships
Recruiting·—·Phase 4·NCT04435834·30 enrolled
Hemodynamic Effects of a High Dose Versus Low Dose Propofol During Induction of Anesthesia.
Recruiting·—·N/A·NCT06651749·70 enrolled
Hemodynamic Effects of Intravenous Paracetamol in Patients Undergoing Emergency Laparotomy
Recruiting·—·N/A·NCT07466108·90 enrolled
Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPH
Recruiting·—·Phase 3·NCT05140525·15 enrolled
Lung Ultrasound-guided Hemodynamic Optimization
Recruiting·—·Phase 3·NCT05481723·350 enrolled
Hemodynamic Measurements of Macrocirculatory and Perfusion Parameters in ICU
Recruiting·—·N/A·NCT05225402·45 enrolled
Page 1 of 6
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)